Gritstone bio Funding: $102M Raised, Series A (2015)
Gritstone bio is based in San Francisco. It has raised $102M in total funding. Latest round: Series A.
Gritstone bio funding overview
Gritstone bio is based in San Francisco. Gritstone bio has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2015. The round record for Gritstone bio runs through 2015; nothing later has been disclosed. Investors on record include Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Gritstone bio at a glance
Total raised
$102M
Latest round
Series A
Latest round date
October 2015
Headquarters
San Francisco
Notable investors
Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital, Transformational Healthcare Opportunity
Frequently asked about Gritstone bio funding
How much has Gritstone bio raised?
Gritstone bio has raised $102M in total disclosed funding across the rounds on record.
Who has invested in Gritstone bio?
Versant Ventures, The Column Group, Clarus Ventures, Frazier Healthcare Partners, Redmile Group, Casdin Capital are named among the investors backing Gritstone bio.
What was the latest Gritstone bio funding round?
The most recent disclosed round is a Series A, announced in October 2015.
Where is Gritstone bio based?
Gritstone bio is based in San Francisco.
When did Gritstone bio last raise?
The last disclosed Gritstone bio round closed in October 2015 at Series A.
Gritstone bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Francisco below to benchmark round size and investor mix.
